[bioundgrd] advanced undergrad seminars -- spring 2006
Rachel McPherson
rachelm at MIT.EDU
Thu Dec 15 17:13:52 EST 2005
December 12, 2005
TO: Biology Majors
FROM: H. Robert Horvitz, Professor of Biology
I am writing to inform you of the exciting Advanced
Undergraduate Seminar courses being offering by the Department of
Biology for the Spring 2006 term. A complete list of the courses,
instructors, and brief course descriptions are enclosed. The topics
are highly varied and encompass areas of genetics, biochemistry,
molecular biology, cell biology and human disease. A student can
take any number of these courses. The courses, which generally
involve four to eight students, are for 6 units, graded pass/fail,
and meet two hours each week. The focus is on reading and discussing
the primary research literature. Most courses have two short written
assignments. Some include field trips to MIT research laboratories
or to commercial sites using technologies discussed in the courses.
The level of each course will be tailored to the students who enroll.
Because of the small size of these courses, we expect students not to
drop these courses once they have begun.
These courses offer a number of special features: small
class size, a high degree of personal contact with the instructor, a
focus on the primary research literature, and an opportunity to
discuss current problems in biology interactively. I believe these
courses greatly enrich an undergraduate's experience. There are
limited alternative opportunities available to undergraduates to
interact closely with instructors who are experienced full-time
researchers; to learn to read, understand, and analyze primary
research papers; and to engage in the type of stimulating discussions
and debates that characterize how science is really done. Most
advanced MIT undergraduates (generally juniors and seniors) have been
sufficiently exposed to the basics of biology to be able to read the
primary literature and appreciate both methodologies and cutting-edge
advances. These courses have two goals: first, to expose students
to the kind of thinking that is central to contemporary biological
research; and second, to impart specific knowledge in particular
areas of biology. These courses are designed to be intellectually
stimulating and also to provide excellent preparation for a variety
of future careers that require an understanding both of what modern
biology is and of how it is done. Students who have taken Advanced
Undergraduate Seminars in the past (different specific courses, same
general design) have been enormously enthusiastic about their
experiences.
I am writing to you before Registration Day this Spring to
encourage you to consider enrolling for one of these seminar courses.
Please feel free to contact any of the instructors to learn more
about their courses.
--
SPRING 2005-2006
7.340 Molecular Mechanism of Aging
Instructors: Danica Chen (danicac at mit.edu, 2-4140; laboratory of
Lenny Guarente)
Agnieszka Czopik (czopik at mit.edu, 3-3567;
laboratory of Lenny Guarente)
Spring 2006. Thursdays, 1-3 pm. Room 68-151.
Aging is a degenerative process that results in decreased viability
and increased susceptibility to diseases. This course will focus on
molecules and molecular pathways that regulate the aging process,
such as the insulin-signaling pathway and members of the Sir2 gene
family. We will discuss the molecular mechanism of calorie
restriction, the only known dietary regimen that extends the
lifespans of a variety of organisms. Other topics will include the
human premature aging disorders Werner's Syndrome and
Hutchinson-Gilford Progeria, the role of oxidative damage and the
mitochondria in aging, and the effects of metabolism on aging. We
will explore the reciprocal effects of aging and immunity at the
cellular and molecular levels and the ways these effects may be
relevant to human biology. The class will be concluded with tours of
a research laboratory at MIT and a biotech company both focused on
aging.
7.342 The RNA Revolution
Instructors: Rickard Sandberg (sandberg at mit.edu, 3-7039;
laboratory of Chris Burge)
Michael Stadler (stadler at mit.edu, 3-7039;
laboratory of Chris Burge)
Spring 2006. Thursdays, 3-5 pm. Room 68-151.
Recent findings have revolutionized our view of the roles of RNA in
biology. For example, short non-coding RNAs (microRNAs and short
interfering RNAs) play key roles in development and cancer by
regulating gene expression. The biology of short non-coding RNAs and
their importance in these processes will be topics for this course.
In addition, the mechanism of alternative splicing explains in part
how humans can express 500,000 different proteins with only 25,000
genes. Alternative splicing, the process by which exons are joined in
different combinations to generate multiple variants of a gene, is
estimated to affect about 75% of all human genes. We will discuss how
alternative splicing diversifies the human protein repertoire,
influences sex determination and courtship behavior in fruit flies
and when disrupted can cause diseases such as spinal muscular
atrophy. Attention will also be given to catalytic RNAs that act in
the ribosome during protein synthesis. In each session we will
critically evaluate both the experimental and the computational
techniques used in the primary literature to foster an understanding
of their strengths and limitations. This course will give you an
overview of the exciting newly emerging roles for RNA.
7.343 Takin' Out the Trash: Quality Control in Cellular Processes
Instructors: Peter Chien (pchien at mit.edu; laboratory of Tania Baker)
Eric Spear (espear at mit.edu; laboratory of Chris Kaiser)
Spring 2006. Wednesdays, 3-5 pm. Room 68-151.
Messenger RNAs are synthesized from a DNA blueprint, the proteins
resulting from these messages are produced using the complex
machinery of the ribosome, and finally these proteins must attain
their proper mature folded state. Although this process is
extraordinarily accurate, care must be taken by the cell to cope with
the inevitable mistakes that occur along this long and complicated
pipeline. To this end, the cell has evolved a broad range of
mechanisms to ensure the quality of the final protein product. For
example, improperly folded proteins are often recognized as aberrant
and subsequently degraded, relieving the cell of the potentially
detrimental effects of a non-functional and abnormal protein. In
this class, we will discuss some of the many mechanisms used for
cellular quality control. We will consider the stresses that can
generate such aberrant protein products and how the cell continuously
fights these challenges. The recognition of misfolded proteins and
how these proteins are targeted to the degradative machinery will
also be discussed. We will consider both prokaryotic and eukaryotic
quality control, drawing attention to the similarities between these
two systems as well as highlighting differences between them. The
importance of these quality control mechanisms will be emphasized
throughout the course by discussing a number of relevant human
diseases, including cystic fibrosis, Huntington's Disease, and
certain types of cancer.
7.344 Toxins, Antibiotics, Protein Engineering and the Ribosome
Instructors: Caroline Koehrer (koehrer at mit.edu, 3-1870; laboratory of Uttam
RajBhandary)
Mandana Sassanfar (mandana at mit.edu, 452-4371;
Education Office)
Spring 2006. Tuesdays, 1-3 pm. Room 68-151.
What do the lethal poison Ricin, Diphtheria toxin, and the widely
used antibiotic tetracycline have in common? They all inhibit protein
synthesis by targeting the cell's translation machinery. Why is Ricin
such a powerful toxin? How does it work? If Diphtheria toxin and
tetracycline also inhibit translation, why do they have such
different consequences? How does resistance to antibiotics like
tetracycline arise? In this course, we will explore the mechanisms of
action of toxins and antibiotics that specifically target components
of the translational apparatus leading to the disruption of protein
synthesis. We will discuss the roles of these antibiotics and toxins
in everyday medicine, the emergence and spread of drug resistance,
and how we might overcome this increasing problem by identifying new
drug targets and designing new drugs. We will also discuss how the
detailed understanding of the structure of the ribosome and the
translation machinery has led to new technologies in protein
engineering and promising applications for human therapy.
7.346 How Abnormal Protein Folding Causes Alzheimer's, Parkinson's, Mad Cow
and Other Neurodegenerative Diseases
Instructor: Atta Ahmad (giftee6 at mit.edu, 3-3707; laboratory of Vernon Ingram)
Spring 2006. Thursdays, 11 am - 1 pm. Room 68-151.
The cause of both Alzheimer's Disease (AD) and Parkinson's Disease
(PD) is abnormal deposition of proteins in brain cells. In addition,
there are 20 other neurological diseases caused by similar protein
deposition. Millions of people suffer from these diseases. The latest
research shows that these diseases arise as a consequence of a
specific series of molecular events. First, a protein assumes a
non-native sticky "misfolded state." Two or more such sticky proteins
associate together to generate a multi protein "oligomeric state."
These oligomers can associate with each other or can recruit newly
formed sticky proteins, thereby growing into bigger thread-like
structures called "amyloid fibrils." These fibrils can deposit either
inside or outside brain cells, disrupting normal biological functions
and resulting in neuronal cell death. Depending on the region of the
brain affected, this cell death leads to visible symptoms, such as
memory loss, loss of cognitive ability, abnormal muscular movements,
involuntary shaking and, in many cases, death. In this course, we
will discuss the processes that trigger protein aggregation (such as,
mutations and environmental effects) with an emphasis on Alzheimer's
Disease, Parkinson's Disease and Mad Cow Disease. The methods used to
study the processes of aggregation (e.g., fluorescence spectroscopy,
circular dichroism, infrared spectroscopy, transmission electron
microscopy, confocal microscopy) will be discussed. We will consider
the consequences of the aberrant proteins on cellular processes. We
will also discuss potential targets for intervening with these
processes and approaches that could lead to possible treatments for
these disorders.
-------------- next part --------------
An HTML attachment was scrubbed...
URL: http://mailman.mit.edu/pipermail/bioundgrd/attachments/20051215/ac6ab0ee/attachment.htm
More information about the bioundgrd
mailing list